ProShares Ultra Nasdaq Biotechnology Rating $52.29 -1.91 (-3.52%) As of 03:50 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy 2.74Holdings in BIB have an aggregate rating of Moderate Buy based on 2,344 analyst ratings issued in the past year covering 254 companies (74.8% of the portfolio).BIB Aggregate Price Target$52.29High Prediction$52.29Average Prediction$52.29Low Prediction$52.29Holdings in BIB have an aggregate price target of $52.29 and a range of $52.29 to $52.29 covering 254 companies (74.8% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy2 Strong Buy rating(s)Buy124 Buy rating(s)Moderate Buy89 Moderate Buy rating(s)Hold33 Hold rating(s)Reduce5 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 100 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.57%GILDGilead Sciences$107.89+1.1%4.4849 of 5 stars2.72$104.52 -3.1%29Positive News6.98%AMGNAmgen$306.86-2.4%4.1765 of 5 stars2.46$314.04 2.3%24Positive News6.78%VRTXVertex Pharmaceuticals$509.04-0.5%3.8617 of 5 stars2.65$506.70 -0.5%26Positive News5.24%REGNRegeneron Pharmaceuticals$634.14-4.1%4.8627 of 5 stars2.76$973.13 53.5%25Positive News3.29%AZNAstraZeneca$73.05-1.4%2.294 of 5 stars3.10$89.75 22.9%10Positive News2.27%ALNYAlnylam Pharmaceuticals$280.96-3.4%4.5739 of 5 stars2.76$312.30 11.2%25Analyst UpgradeNews Coverage1.48%BIIBBiogen$139.16-1.7%4.8475 of 5 stars2.43$213.33 53.3%30News CoveragePositive News1.42%ARGXargenx$605.52-0.4%3.4777 of 5 stars2.91$687.00 13.5%23Positive News1.26%SNYSanofi$55.45-0.9%3.7716 of 5 stars3.00$62.50 12.7%51.11%SMMTSummit Therapeutics$20.24-2.2%2.3948 of 5 stars2.90$34.11 68.5%101.06%RPRXRoyalty Pharma$33.76+0.0%4.7735 of 5 stars3.00$41.60 23.2%6Positive News1.01%ITCIIntra-Cellular Therapies$131.703.6048 of 5 stars2.47$106.08 -19.5%15Positive News1.00%INSMInsmed$78.54-1.1%3.8212 of 5 stars3.00$94.00 19.7%161.00%UTHRUnited Therapeutics$316.73-1.0%4.4039 of 5 stars2.67$388.25 22.6%12Insider Trade0.99%ILMNIllumina$87.53-0.6%4.6466 of 5 stars2.48$140.90 61.0%21Positive News0.97%MRNAModerna$33.85-0.9%4.1053 of 5 stars2.04$59.00 74.3%240.96%BMRNBioMarin Pharmaceutical$71.53-0.6%4.9852 of 5 stars2.71$94.00 31.4%24Analyst Revision0.95%INCYIncyte$62.08-1.1%4.8188 of 5 stars2.21$74.88 20.6%19Analyst Forecast0.83%ONCBeigene$250.47-1.1%1.2589 of 5 stars3.00$310.00 23.8%30.82%NBIXNeurocrine Biosciences$116.18+0.5%4.8916 of 5 stars2.83$165.24 42.2%23Positive News0.79%VTRSViatris$8.95-3.8%2.0057 of 5 stars1.75$10.50 17.3%40.76%EXELExelixis$37.710.0%4.6681 of 5 stars2.50$37.59 -0.3%20Positive News0.74%MEDPMedpace$324.51-1.8%4.1484 of 5 stars2.38$376.30 16.0%13Analyst UpgradeNews CoveragePositive News0.71%BNTXBioNTech$97.05-3.6%3.2808 of 5 stars2.89$143.73 48.1%180.67%ASNDAscendis Pharma A/S$161.04-4.1%3.0809 of 5 stars2.93$204.64 27.1%14News CoveragePositive NewsGap Up0.67%PCVXVaxcyte$71.90-2.6%2.5198 of 5 stars3.00$147.50 105.1%9Positive News0.67%SRPTSarepta Therapeutics$73.61-3.6%4.5729 of 5 stars2.83$167.41 127.4%230.61%JAZZJazz Pharmaceuticals$135.25-4.8%4.9477 of 5 stars2.93$187.71 38.8%14Positive NewsHigh Trading Volume0.58%HALOHalozyme Therapeutics$64.84+1.3%4.2843 of 5 stars2.60$62.78 -3.2%10Positive News0.56%ROIVRoivant Sciences$10.67-1.5%1.9257 of 5 stars3.00$17.10 60.3%6Insider Trade0.55%MDGLMadrigal Pharmaceuticals$343.29-0.9%3.9589 of 5 stars2.80$378.44 10.2%10Positive News0.52%TEMTempus AI$58.57-0.7%1.2112 of 5 stars2.50$61.18 4.5%12High Trading Volume0.48%RVMDRevolution Medicines$38.45-2.3%4.1185 of 5 stars3.08$66.31 72.5%130.45%BBIOBridgeBio Pharma$36.74-1.3%4.5879 of 5 stars2.91$52.90 44.0%11Analyst Forecast0.43%AXSMAxsome Therapeutics$120.36-6.8%4.7642 of 5 stars3.00$167.36 39.0%15Positive News0.41%BPMCBlueprint Medicines$93.08-2.3%2.9068 of 5 stars2.70$124.95 34.2%230.40%ALKSAlkermes$33.88-2.6%4.3261 of 5 stars2.69$38.46 13.5%13Positive News0.39%GHGuardant Health$46.46-0.6%3.8009 of 5 stars3.00$48.40 4.2%200.38%CYTKCytokinetics$44.55-4.3%4.3591 of 5 stars2.94$82.00 84.1%18Positive News0.38%IONSIonis Pharmaceuticals$32.27-3.5%4.277 of 5 stars2.70$59.44 84.2%20Analyst Forecast0.38%KRYSKrystal Biotech$192.30-1.1%4.791 of 5 stars3.00$220.00 14.4%8Positive News0.37%NUVLNuvalent$74.98-2.8%1.9713 of 5 stars2.92$113.10 50.8%13Positive News0.33%VRNAVerona Pharma$66.18-0.9%1.4825 of 5 stars3.14$69.14 4.5%7Positive News0.32%ADMAADMA Biologics$20.22-0.5%2.2846 of 5 stars3.25$22.50 11.3%4Positive News0.31%PTCTPTC Therapeutics$56.27-1.3%3.4987 of 5 stars2.53$64.00 13.7%15Positive News0.28%ACLXArcellx$72.16-0.4%2.2121 of 5 stars3.13$108.46 50.3%150.28%SWTXSpringWorks Therapeutics$47.21-2.7%2.7593 of 5 stars3.00$73.20 55.1%5Positive News0.27%RNAAvidity Biosciences$32.10-3.6%1.874 of 5 stars3.00$66.69 107.8%130.26%CRSPCRISPR Therapeutics$40.89-4.1%3.0474 of 5 stars2.48$73.11 78.8%210.26%RAREUltragenyx Pharmaceutical$38.69-1.7%4.3754 of 5 stars2.93$91.71 137.0%14Positive News0.24%PTGXProtagonist Therapeutics$51.05-2.8%2.9009 of 5 stars3.00$62.56 22.5%9Positive News0.24%SRRKScholar Rock$33.28-1.6%3.6809 of 5 stars3.14$40.86 22.8%7Analyst ForecastInsider Trade0.23%CRNXCrinetics Pharmaceuticals$35.07-2.4%4.3219 of 5 stars2.92$73.00 108.2%13Analyst ForecastNews Coverage0.23%MRUSMerus$46.98-3.7%2.0176 of 5 stars3.13$85.31 81.6%160.23%RYTMRhythm Pharmaceuticals$52.91-1.5%4.2976 of 5 stars2.92$69.46 31.3%13Analyst ForecastAnalyst Revision0.22%APLSApellis Pharmaceuticals$23.76-2.1%4.0747 of 5 stars2.63$45.53 91.6%190.22%ALVOAlvotech$11.66+0.9%2.004 of 5 stars3.00$18.00 54.4%2Upcoming Earnings0.22%AKROAkero Therapeutics$45.24+0.4%4.2234 of 5 stars3.00$76.29 68.6%90.22%LEGNLegend Biotech$35.05-3.5%2.0403 of 5 stars2.92$79.00 125.4%120.21%ACADACADIA Pharmaceuticals$17.11-0.7%4.452 of 5 stars2.50$23.93 39.9%160.21%IMVTImmunovant$18.19-6.4%2.4948 of 5 stars3.00$41.00 125.4%10High Trading Volume0.20%AMRXAmneal Pharmaceuticals$8.53-4.0%3.4702 of 5 stars3.00$10.80 26.6%5Positive News0.20%XENEXenon Pharmaceuticals$34.90-4.3%2.4861 of 5 stars3.00$57.38 64.4%90.19%FOLDAmicus Therapeutics$8.62-0.8%4.2791 of 5 stars2.78$16.75 94.3%9Positive News0.18%EWTXEdgewise Therapeutics$22.80-2.4%1.7849 of 5 stars2.88$45.38 99.0%8Gap Down0.18%RXRXRecursion Pharmaceuticals$6.53-3.8%2.2231 of 5 stars2.40$8.25 26.3%50.18%VCYTVeracyte$33.69+1.6%4.0198 of 5 stars2.67$43.22 28.3%90.17%TWSTTwist Bioscience$44.25-1.5%2.8493 of 5 stars2.70$54.40 22.9%10News Coverage0.16%DNLIDenali Therapeutics$14.12-4.3%4.3664 of 5 stars2.94$37.20 163.5%18Positive News0.16%KYMRKymera Therapeutics$31.82-5.6%1.3698 of 5 stars2.87$56.36 77.1%15Positive News0.16%NAMSNewAmsterdam Pharma$23.41-2.5%2.6471 of 5 stars3.00$43.33 85.1%6High Trading Volume0.16%VCELVericel$47.96+0.0%2.731 of 5 stars3.00$62.29 29.9%7News CoveragePositive News0.15%BEAMBeam Therapeutics$23.22-3.3%3.3496 of 5 stars3.00$50.82 118.9%140.15%IBRXImmunityBio$2.74-3.9%2.2442 of 5 stars3.00$12.19 344.8%5Positive News0.15%LGNDLigand Pharmaceuticals$109.69-1.8%4.7524 of 5 stars3.00$147.00 34.0%6Positive News0.15%MIRMMirum Pharmaceuticals$47.06+0.1%3.2674 of 5 stars3.09$58.20 23.7%11Positive NewsGap Up0.15%NVCRNovoCure$18.77-5.1%3.6151 of 5 stars2.80$35.80 90.7%5Positive News0.14%CGONCG Oncology$27.54-3.5%1.8411 of 5 stars3.10$63.88 131.9%10Analyst ForecastNews Coverage0.14%ARWRArrowhead Pharmaceuticals$14.73-5.0%3.6461 of 5 stars2.60$41.44 181.4%100.14%HRMYHarmony Biosciences$32.99-3.7%4.2901 of 5 stars3.00$53.33 61.7%9News CoveragePositive News0.14%ZLABZai Lab$35.40-0.8%2.3996 of 5 stars3.00$47.37 33.8%4Positive News0.13%DVAXDynavax Technologies$13.98+1.0%4.5538 of 5 stars2.33$21.50 53.8%3Options VolumePositive News0.13%AGIOAgios Pharmaceuticals$30.76-4.8%4.3488 of 5 stars2.56$56.57 83.9%9Positive News0.13%APGEApogee Therapeutics$39.89-2.3%2.9867 of 5 stars3.00$92.17 131.1%6Positive NewsHigh Trading Volume0.13%SUPNSupernus Pharmaceuticals$33.05+1.1%1.3419 of 5 stars2.33$36.00 8.9%3Analyst Downgrade0.13%TARSTarsus Pharmaceuticals$51.33-2.0%1.7811 of 5 stars3.00$63.67 24.0%70.13%VERAVera Therapeutics$26.95-0.7%3.0968 of 5 stars3.20$64.67 140.0%10Positive News0.12%ARQTArcutis Biotherapeutics$17.11-1.0%1.2653 of 5 stars2.83$18.80 9.9%6Positive NewsGap Up0.12%BCRXBioCryst Pharmaceuticals$8.07+0.2%4.4395 of 5 stars2.86$15.57 93.0%7Positive News0.12%IDYAIDEAYA Biosciences$18.01-3.1%3.5371 of 5 stars2.93$53.58 197.5%15Positive News0.12%JANXJanux Therapeutics$30.83-2.9%3.5421 of 5 stars3.08$92.44 199.9%12Positive News0.12%TVTXTravere Therapeutics$21.01-1.3%2.9616 of 5 stars2.93$30.62 45.7%14Positive News0.11%CNTACentessa Pharmaceuticals$15.81-4.9%2.3676 of 5 stars3.00$26.00 64.5%7Earnings ReportUpcoming EarningsNews Coverage0.11%IRONDisc Medicine$52.79-1.7%3.2278 of 5 stars3.09$93.80 77.7%110.11%WVEWave Life Sciences$9.44-6.3%4.5563 of 5 stars3.00$22.60 139.4%10Positive News0.10%ANIPANI Pharmaceuticals$66.33+0.5%3.4555 of 5 stars3.00$79.75 20.2%9High Trading Volume0.10%INDVIndivior$9.58-5.1%3.4371 of 5 stars3.25$15.00 56.6%4Positive News0.10%MNKDMannKind$5.22-0.2%2.3886 of 5 stars3.13$9.21 76.5%80.09%DYNDyne Therapeutics$11.40-8.0%3.2288 of 5 stars3.07$47.46 316.3%150.09%GPCRStructure Therapeutics$20.34-3.4%2.2754 of 5 stars3.00$81.29 299.6%8 This page (NASDAQ:BIB) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.